CVE:ADK - Diagnos Stock Price, Price Target & More

C$0.07 0.00 (0.00 %)
(As of 04/20/2018 05:00 AM ET)
Previous CloseC$0.07
Today's RangeC$0.07 - C$0.08
52-Week RangeC$0.07 - C$0.20
Volume32,000 shs
Average Volume779,414 shs
Market CapitalizationC$14.66 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35

About Diagnos (CVE:ADK)

DIAGNOS Inc. provides data mining and interpretation consulting services, and designs data analytics software products. The Company operates through two segments: Healthcare and Natural resources. Its Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis (CARA), a software tool, which assists health specialists in the detection of diabetic retinopathy. CARA is a hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. Its Natural resources segment offers data mining consulting services through Computer Aided Resource Detection System (CARDS), a software tool used to assist exploration companies in identifying mining deposits. In addition, it offers project management services. The Company operates in Canada, the United Arab Emirates, India, Mexico, Switzerland, the United States, Poland and Colombia.

Receive ADK News and Ratings via Email

Sign-up to receive the latest news and ratings for ADK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCVE:ADK
CUSIPN/A
Phone+1-450-6788882

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-58.07%
Return on EquityN/A
Return on Assets-90.29%

Miscellaneous

EmployeesN/A
Outstanding Shares172,421,000

How to Become a New Pot Stock Millionaire

Diagnos (CVE:ADK) Frequently Asked Questions

What is Diagnos' stock symbol?

Diagnos trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

Who are some of Diagnos' key competitors?

Who are Diagnos' key executives?

Diagnos' management team includes the folowing people:
  • Georges L. Hebert, Chairman of the Board (Age 66)
  • Andre Larente, President, Director
  • Marc-Andre Massue, Chief Financial Officer, Vice President
  • Guillermo Moreno Robles, Vice President - Health Care Business Development of Latin America
  • Houssem Ben Tahar, Vice-President - Development and Business Intelligence
  • Hadi Chakor, Chief Medical Officer
  • Tristam Coffin, Director
  • Jean-Yves Therien, Director

Has Diagnos been receiving favorable news coverage?

Media coverage about ADK stock has been trending somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Diagnos earned a daily sentiment score of 0.24 on Accern's scale. They also gave press coverage about the company an impact score of 46.98 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Diagnos?

Shares of ADK and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Diagnos' stock price today?

One share of ADK stock can currently be purchased for approximately C$0.07.

How big of a company is Diagnos?

Diagnos has a market capitalization of C$14.66 million.

How can I contact Diagnos?

Diagnos' mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The company can be reached via phone at +1-450-6788882.


MarketBeat Community Rating for Diagnos (ADK)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  10
MarketBeat's community ratings are surveys of what our community members think about Diagnos and other stocks. Vote "Outperform" if you believe ADK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ADK will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Diagnos (CVE:ADK) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/20/2016 forward)

Earnings

Dividends

Diagnos (CVE:ADK) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Diagnos (CVE ADK) Insider Trading and Institutional Ownership History

Insider Trading History for Diagnos (CVE:ADK)

Diagnos (CVE ADK) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2018Corporation DundeeInsiderSell2,026,000C$0.09C$182,340.00
(Data available from 1/1/2013 forward)

Headlines

Diagnos (CVE ADK) News Headlines

Source:
DateHeadline
DIAGNOS Welcomes Dr. Reid Maclellan to the Board of DirectorsDIAGNOS Welcomes Dr. Reid Maclellan to the Board of Directors
globenewswire.com - April 4 at 3:20 PM
DIAGNOS Announces the Opening of a Screening Clinic at Chaparrals Health Management Wellness Center for ... - GlobeNewswire (press release)DIAGNOS Announces the Opening of a Screening Clinic at Chaparral's Health Management Wellness Center for ... - GlobeNewswire (press release)
globenewswire.com - March 15 at 7:07 AM
Following a successful year, DIAGNOS Announces a One-Year Agreement in United Arabs Emirates with a Major ... - GlobeNewswire (press release)Following a successful year, DIAGNOS Announces a One-Year Agreement in United Arabs Emirates with a Major ... - GlobeNewswire (press release)
globenewswire.com - March 7 at 3:19 PM
After Successful Screening of 2500 patients as part of a Pilot Project with Kanhoor Medical Co, DIAGNOS will Now ... - GlobeNewswire (press release)After Successful Screening of 2500 patients as part of a Pilot Project with Kanhoor Medical Co, DIAGNOS will Now ... - GlobeNewswire (press release)
globenewswire.com - February 28 at 3:18 PM
DIAGNOS Provides a Market Update on Recent Trading - GlobeNewswire (press release)DIAGNOS Provides a Market Update on Recent Trading - GlobeNewswire (press release)
globenewswire.com - February 15 at 3:15 PM
Corporation Dundee Sells 2,026,000 Shares of Diagnos Inc (ADK) StockCorporation Dundee Sells 2,026,000 Shares of Diagnos Inc (ADK) Stock
www.americanbankingnews.com - February 8 at 4:02 AM
FLIR Systems (FLIR) Launches Thermal Camera Development Kit - NasdaqFLIR Systems (FLIR) Launches Thermal Camera Development Kit - Nasdaq
www.nasdaq.com - January 11 at 8:59 AM
Police: Man arrested after person found dead in south Sacramento homePolice: Man arrested after person found dead in south Sacramento home
www.msn.com - January 9 at 8:48 AM
FLIR Systems (FLIR) Launches Thermal Camera Development KitFLIR Systems (FLIR) Launches Thermal Camera Development Kit
www.zacks.com - January 9 at 8:48 AM
Qualcomm Introduces Breakthrough Low Power Bluetooth Audio SoC Series for Wireless Earbuds and HearablesQualcomm Introduces Breakthrough Low Power Bluetooth Audio SoC Series for Wireless Earbuds and Hearables
www.prnewswire.com - January 8 at 6:17 PM
FLIR Releases High-Resolution Thermal Camera Development Kit for Self-Driving Cars - GlobeNewswire (press release)FLIR Releases High-Resolution Thermal Camera Development Kit for Self-Driving Cars - GlobeNewswire (press release)
globenewswire.com - January 8 at 11:42 AM
Outdoors: Toothbrush trip a brush with Adirondack historyOutdoors: Toothbrush trip a brush with Adirondack history
www.msn.com - December 29 at 8:31 AM
UPDATE 1-Bain gets 87 pct of Japans Asatsu-DK in tender offer -filingUPDATE 1-Bain gets 87 pct of Japan's Asatsu-DK in tender offer -filing
www.businessinsider.com - December 8 at 8:39 AM
Bain wins WPP support for $1.4 billion Asatsu-DK buyBain wins WPP support for $1.4 billion Asatsu-DK buy
www.reuters.com - December 8 at 8:39 AM
Breakingviews - WPP rebrands its weak Tokyo defenceBreakingviews - WPP rebrands its weak Tokyo defence
www.reuters.com - November 21 at 4:04 PM
Bain cleared to buy Japanese advertising agencyBain cleared to buy Japanese advertising agency
www.ft.com - November 21 at 4:04 PM
WPP accepts Bains offer for Japans ADK, says BainWPP accepts Bain's offer for Japan's ADK, says Bain
finance.yahoo.com - November 21 at 4:04 PM
WPP agrees to sell stake in Japans Asatsu-DK to BainWPP agrees to sell stake in Japan's Asatsu-DK to Bain
www.reuters.com - November 21 at 3:03 AM
WPP to sell stake in ADK to Bain Capital: reportWPP to sell stake in ADK to Bain Capital: report
www.marketwatch.com - November 21 at 3:03 AM
UPDATE 1-Advertiser WPP prepared to up ADK stake if Bain offer fails - ReutersUPDATE 1-Advertiser WPP prepared to up ADK stake if Bain offer fails - Reuters
www.reuters.com - November 16 at 3:42 PM
AdCare Health Systems Viewed Through The Eyes Of A Preferred Investor - Another UpdateAdCare Health Systems Viewed Through The Eyes Of A Preferred Investor - Another Update
seekingalpha.com - November 14 at 6:17 AM
WPP mounts legal challenge over ADK break-upWPP mounts legal challenge over ADK break-up
www.ft.com - November 3 at 10:27 AM

SEC Filings

Diagnos (CVE:ADK) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Diagnos (CVE ADK) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.